Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors

Pedro Brandão, Óscar López, Luisa Leitzbach, Holger Stark, José G. Fernández-Bolaños, Anthony J. Burke, Marta Pineiro

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Molecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as the key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds 4eca and 5dab exhibited great potential as selective butyrylcholinesterase inhibitors, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer's disease.

Original languageEnglish
Pages (from-to)1718-1725
Number of pages8
JournalACS Medicinal Chemistry Letters
Volume12
Issue number11
DOIs
Publication statusPublished - 11 Nov 2021
Externally publishedYes

Keywords

  • Alzheimer's disease
  • Isatin
  • Ugi reaction
  • multicomponent reactions
  • oxindole-lactam hybrids

Fingerprint

Dive into the research topics of 'Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors'. Together they form a unique fingerprint.

Cite this